406 related articles for article (PubMed ID: 24354792)
1. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
[TBL] [Abstract][Full Text] [Related]
2. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
[TBL] [Abstract][Full Text] [Related]
3. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
[TBL] [Abstract][Full Text] [Related]
4. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).
Ramachandran R; Mihara K; Chung H; Renaux B; Lau CS; Muruve DA; DeFea KA; Bouvier M; Hollenberg MD
J Biol Chem; 2011 Jul; 286(28):24638-48. PubMed ID: 21576245
[TBL] [Abstract][Full Text] [Related]
6. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
Ramachandran R; Hollenberg MD
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
[TBL] [Abstract][Full Text] [Related]
7. Agonists and antagonists of protease activated receptors (PARs).
Barry GD; Le GT; Fairlie DP
Curr Med Chem; 2006; 13(3):243-65. PubMed ID: 16475935
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of protease-activated receptor signaling.
Canto I; Soh UJ; Trejo J
Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
[TBL] [Abstract][Full Text] [Related]
10. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).
Thibeault PE; LeSarge JC; Arends D; Fernandes M; Chidiac P; Stathopulos PB; Luyt LG; Ramachandran R
J Biol Chem; 2020 Feb; 295(8):2520-2540. PubMed ID: 31892516
[TBL] [Abstract][Full Text] [Related]
12. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):677-85. PubMed ID: 16800728
[TBL] [Abstract][Full Text] [Related]
13. Cofactoring and dimerization of proteinase-activated receptors.
Lin H; Liu AP; Smith TH; Trejo J
Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
[TBL] [Abstract][Full Text] [Related]
14. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
Hansen KK; Saifeddine M; Hollenberg MD
Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Opportunities in Protease-Activated Receptor Drug Development.
Hamilton JR; Trejo J
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():349-373. PubMed ID: 27618736
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).
Mihara K; Ramachandran R; Renaux B; Saifeddine M; Hollenberg MD
J Biol Chem; 2013 Nov; 288(46):32979-90. PubMed ID: 24052258
[TBL] [Abstract][Full Text] [Related]
17. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
Hollenberg MD
J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).
Chandrabalan A; Ramachandran R
FEBS J; 2021 Apr; 288(8):2697-2726. PubMed ID: 33742547
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
[TBL] [Abstract][Full Text] [Related]
20. [Development of agonists/antagonists for protease-activated receptors (PARs) and the possible therapeutic application to gastrointestinal diseases].
Sekiguchi F
Yakugaku Zasshi; 2005 Jun; 125(6):491-8. PubMed ID: 15930817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
